Dusseldorf - Delayed Quote EUR

AbbVie Inc (4AB.DU)

165.80

-0.40

(-0.24%)

At close: June 9 at 7:56:39 PM GMT+2

1 S&P 500 Stock with Competitive Advantages and 2 to Steer Clear Of

While the S&P 500 (^GSPC) includes industry leaders, not every stock in the index is a winner. Some companies are past their prime, weighed down by poor execution, weak financials, or structural headwinds.

StockStory 23 hours ago

^GSPC

ABBV

WST
3 Stocks With Mouthwatering Dividends You Can Buy Right Now

AbbVie is a Dividend King with a strong product lineup. Bristol Myers Squibb offers a high dividend yield and has underrated growth potential. Pfizer's dividend and underlying business are safer than they might seem at first glance.

Motley Fool yesterday

ABBV

CELG-RT

PFE
Challenges pharma companies face in push into US manufacturing

Yahoo Finance senior health reporter Anjalee Khemlani explains the pharmaceutical industry's push into domestic manufacturing in the US, as a reshoring tactic to tighten up the supply chain. Planning can still take several years to be finalized and face cost barriers amid tariffs. To watch more expert insights and analysis on the latest market action, check out more Market Domination here.

Yahoo Finance Video 3 days ago

SNY

SNYNF

LLY
Can New Cancer Drug Emrelis Drive AbbVie's Oncology Franchise?

Emrelis wins FDA approval, marking ABBV's first lung cancer drug and strengthening its oncology reach into solid tumors.

Zacks 3 days ago

ABBV

AZN

REGN
AbbVie (ABBV) Increases Despite Market Slip: Here's What You Need to Know

The latest trading day saw AbbVie (ABBV) settling at $187.66, representing a +0.17% change from its previous close.

Zacks 4 days ago

ABBV
Billionaire Ken Griffin Just Bought More Shares of These Unstoppable Dividend Stocks

Investors have been hit with a great deal of volatility and uncertainty in the markets lately. Many investors might prefer to do their own research before buying shares of a company, but it's still a good idea to pay attention to some of the moves more experienced names on Wall Street make. Take Ken Griffin, a successful money manager and the billionaire CEO of Citadel Advisors, the hedge fund he founded.

Motley Fool 4 days ago

MDT

ABBV
AbbVie (ABBV): Buy, Sell, or Hold Post Q1 Earnings?

While the broader market has struggled with the S&P 500 down 1.8% since December 2024, AbbVie has surged ahead as its stock price has climbed by 6.7% to $188.02 per share. This was partly thanks to its solid quarterly results, and the run-up might have investors contemplating their next move.

StockStory 5 days ago

ABBV
Profit From the Silver Tsunami: Must-Watch Senior Care & Aging Stocks

BSX, ABBV, AMGN and DXCM are tapping into the aging boom with cutting-edge tech, chronic care drugs and senior-focused innovations.

Zacks 5 days ago

ABBV

AMGN

DXCM
3 Cheap Dividend Growth Stocks to Buy Right Now

All three are fairly cheap options, trading at modest earnings multiples. Dividend growth stocks can be ideal long-term options for any investment portfolio. There are many solid dividend stocks right now worth considering because they trade at modest valuations.

Motley Fool 5 days ago

ABBV

VZ

XOM
ASCO25: AbbVie flexes ADC Phase I data as NSCLC market opportunity beckons

AbbVie’s telisotuzumab adizutecan achieved an ORR of 63% in EGFR-mutant NSCLC patients, with current ADC options in this population lacking.

Clinical Trials Arena 6 days ago

ABBV
AbbVie Invites People Living with Migraine to Enter the Second Annual AbbVie Migraine Career Catalyst Award™ Contest to Support Their Professional Goals

AbbVie (NYSE: ABBV) today announced the second annual AbbVie Migraine Career Catalyst Award™ contest is now accepting entries. AbbVie is proud to continue this nationwide initiative supporting people living with migraine by awarding 20 entrants with $2,500 each that they may use to pursue their personal, professional, and educational goals.

PR Newswire 6 days ago

ABBV
AbbVie to Present at the Goldman Sachs 46th Annual Global Healthcare Conference

AbbVie (NYSE: ABBV) will participate in the Goldman Sachs 46th Annual Global Healthcare Conference on Tuesday, June 10, 2025. Management will participate in a fireside chat at 10:20 a.m. Central time.

PR Newswire 6 days ago

ABBV
High Growth Tech Stocks To Watch In The US June 2025

Over the last 7 days, the United States market has risen by 2.0% and is up 12% over the past year, with earnings forecasted to grow by 14% annually. In such a dynamic environment, identifying high growth tech stocks involves looking for companies that demonstrate strong innovation potential and robust financial health to capitalize on these favorable conditions.

Simply Wall St. 6 days ago

ABBV

FICO

ORCL
AbbVie (ABBV) Gains As Market Dips: What You Should Know

The latest trading day saw AbbVie (ABBV) settling at $186.11, representing a +0.26% change from its previous close.

Zacks 10 days ago

ABBV

^GSPC
AbbVie Partners with Chicago Cubs on "Striking Out Cancer"

AbbVie (NYSE: ABBV) announced a multi-year partnership with the Chicago Cubs to support people living with cancer through a campaign called "Striking Out Cancer" which starts today when the Chicago Cubs play the Cincinnati Reds. As part of the first year of the partnership, AbbVie will make a $233 donation for every strikeout by a Chicago Cubs pitcher at home during the 2025 regular season. The donation amount is in honor of the approximately 233 Americans diagnosed with cancer every hour, accor

PR Newswire 10 days ago

ABBV
The Zacks Analyst Blog Highlights Berkshire Hathaway, AbbVie, Intuitive Surgical, Hamilton Beach Brands and AXIL Brands

Zacks highlights strong showings from ABBV, ISRG, HBB and AXIL, while BRK.B gains on insurance growth and capital strength despite headwinds.

Zacks 10 days ago

ABBV

HBB
AbbVie’s ADC win shows how pharma can break through in solid tumors

An oncology pivot recently paid off for the large pharma, which scored a milestone nod for its lead ADC.

Pharma Voice 10 days ago

ABBV

ADCT
Top Research Reports for Berkshire Hathaway, AbbVie & Intuitive Surgical

Berkshire Hathaway, AbbVie and Intuitive Surgical beat estimates as analysts highlight growth drivers, headwinds and strategic moves in new reports.

Zacks 11 days ago

ABBV

HBB
AbbVie Stock Down Around 13% in 3 Months: Time to Buy the Dip?

ABBV drops 12.6% in three months, but rising Skyrizi and Rinvoq sales, pipeline strength, and 2025 growth outlook support staying invested.

Zacks 11 days ago

ABBV
AbbVie Inc. (ABBV)’s Pipeline Advances with Temab-A and ABBV-706, Shares Flat

AbbVie Inc. (NYSE:ABBV) has spotlighted major advancements in its oncology pipeline at the ASCO 2025 Annual Meeting, unveiling promising clinical data for its next-generation antibody-drug conjugates (ADCs), Temab-A and ABBV-706. Temab-A, a c-Met-targeting ADC, achieved a 63% objective response rate in pre-treated EGFR-mutated non-small cell lung cancer (NSCLC) patients, with over half maintaining their response […]

Insider Monkey 12 days ago

ABBV

Performance Overview

Return	4AB.DU	S&P 500 (^GSPC)
YTD	+0.00%	+2.11%
1-Year	+10.02%	+12.32%
3-Year	+34.03%	+49.48%

News

Life

Entertainment

Finance

Sports

New on Yahoo

Yahoo Finance

AbbVie Inc (4AB.DU)

1 S&P 500 Stock with Competitive Advantages and 2 to Steer Clear Of

3 Stocks With Mouthwatering Dividends You Can Buy Right Now

Challenges pharma companies face in push into US manufacturing

Can New Cancer Drug Emrelis Drive AbbVie's Oncology Franchise?

AbbVie (ABBV) Increases Despite Market Slip: Here's What You Need to Know

Billionaire Ken Griffin Just Bought More Shares of These Unstoppable Dividend Stocks

AbbVie (ABBV): Buy, Sell, or Hold Post Q1 Earnings?

Profit From the Silver Tsunami: Must-Watch Senior Care & Aging Stocks

3 Cheap Dividend Growth Stocks to Buy Right Now

ASCO25: AbbVie flexes ADC Phase I data as NSCLC market opportunity beckons

AbbVie Invites People Living with Migraine to Enter the Second Annual AbbVie Migraine Career Catalyst Award™ Contest to Support Their Professional Goals

AbbVie to Present at the Goldman Sachs 46th Annual Global Healthcare Conference

High Growth Tech Stocks To Watch In The US June 2025

AbbVie (ABBV) Gains As Market Dips: What You Should Know

AbbVie Partners with Chicago Cubs on "Striking Out Cancer"

The Zacks Analyst Blog Highlights Berkshire Hathaway, AbbVie, Intuitive Surgical, Hamilton Beach Brands and AXIL Brands

AbbVie’s ADC win shows how pharma can break through in solid tumors

Top Research Reports for Berkshire Hathaway, AbbVie & Intuitive Surgical

AbbVie Stock Down Around 13% in 3 Months: Time to Buy the Dip?

AbbVie Inc. (ABBV)’s Pipeline Advances with Temab-A and ABBV-706, Shares Flat

Performance Overview